| 证券代码 | CXRX.O |
| 证券名称 | Concordia International Corp |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2015-06-29 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | USD |
| 公司名称 | Concordia International Corp. |
| 注册地址 | 加拿大安大略省 |
| 办公地址 | 277 Lakeshore Road East, Suite 302, Oakville, Ontario, Canada |
| 成立日期 | 2010-01-20 |
| 董事会主席 | - |
| 公司属地 | Canada 加拿大 |
| 公司网址 | www.concordiarx.com |
| 电话 | +1 (905) 842-5150 |
| 传真 | +1 (905) 842-5154 |
| 公司简介 | Concordia International Corp. is a diverse, international specialty pharmaceutical company focused on generic and legacy pharmaceutical products and orphan drugs. The Company has an international footprint with sales in more than 100 countries, and has a diversified portfolio of more than 200 established, off-patent molecules that make up more than 1,300 SKUs. Concordia also markets orphan drugs through its Orphan Drugs Division, consisting of Photofrin for the treatment of certain rare forms of cancer. Concordia operates out of facilities in Oakville, Ontario and, through its subsidiaries, operates out of facilities in Bridgetown, Barbados; London, England and Mumbai, India. |